scholarly article | Q13442814 |
P356 | DOI | 10.1159/000188848 |
P698 | PubMed publication ID | 8684533 |
P2093 | author name string | T Kokubo | |
Y Kobayashi | |||
A Horii | |||
Y Hiki | |||
S Tateno | |||
P433 | issue | 2 | |
P304 | page(s) | 237-242 | |
P577 | publication date | 1996-01-01 | |
P1433 | published in | The Nephron Journals | Q15745443 |
P1476 | title | Steroid therapy during the early stage of progressive IgA nephropathy. A 10-year follow-up study. | |
P478 | volume | 72 |
Q33932591 | A multicenter randomized controlled trial of tonsillectomy combined with steroid pulse therapy in patients with immunoglobulin A nephropathy |
Q35894999 | A treatment dilemma in adult immunoglobulin A nephropathy: what is the appropriate target, preservation of kidney function or induction of clinical remission? |
Q87393387 | Chapter 10: Immunoglobulin A nephropathy |
Q46744590 | Clinical assessment of low-dose steroid therapy for patients with IgA nephropathy: a prospective study in a single center |
Q28361134 | Clinical course of patients with IgA nephropathy between combined treatment of immunosuppressive agents and ACE inhibitor and ACE inhibitor alone |
Q36234400 | Comparison of immunosuppressive therapies for IgA nephropathy after tonsillectomy: three-course versus one-course steroid pulse combined with mizoribine |
Q50230374 | Comparison of oral steroids with tonsillectomy plus steroid pulse therapy in patients with IgA nephropathy |
Q84196917 | Complete remission within 2 years predicts a good prognosis after methylprednisolone pulse therapy in patients with IgA nephropathy |
Q37108501 | Continental variations in IgA nephropathy among Asians |
Q44423474 | Controlled, prospective trial of steroid treatment in IgA nephropathy: a limitation of low-dose prednisolone therapy |
Q44419929 | Corticosteroids in IgA nephropathy: a randomised controlled trial |
Q58761828 | Corticosteroids pulse therapy and oral corticosteroids therapy for IgA nephropathy patients with advanced chronic kidney disease: results of a multicenter, large-scale, long-term observational cohort study |
Q73453299 | Early treatment with corticosteroids ameliorates proteinuria, proliferative lesions, and mesangial phenotypic modulation in adult diffuse proliferative IgA nephropathy |
Q35995685 | Enhanced intrarenal oxidative stress and angiotensinogen in IgA nephropathy patients. |
Q84978295 | Evidence-based practice guideline for the treatment of CKD |
Q46846514 | Histologically advanced IgA nephropathy treated successfully with prednisolone and cyclophosphamide |
Q36577108 | IgA glomerulonephritis: beyond angiotensin-converting enzyme inhibitors |
Q55509866 | Immunosuppressive Treatment in Children With IgA Nephropathy and the Clinical Value of Podocytopathic Features. |
Q24188035 | Immunosuppressive agents for treating IgA nephropathy |
Q24247680 | Immunosuppressive agents for treating IgA nephropathy |
Q90254423 | Immunosuppressive agents for treating IgA nephropathy |
Q46715751 | Long-term follow-up of patients with IgA nephropathy treated with prednisolone and cyclophosphamide therapy |
Q51680137 | Mechanism of onset and exacerbation of chronic glomerulonephritis and its treatment. |
Q51595672 | New treatment for IgA nephropathy: enteric budesonide targeted to the ileocecal region ameliorates proteinuria. |
Q35128270 | Prognosis in IgA nephropathy: 30-year analysis of 1,012 patients at a single center in Japan |
Q33863555 | Rationales for treating IgA nephropathies |
Q57945954 | References |
Q86715995 | Renal outcome after tonsillectomy plus corticosteroid pulse therapy in patients with immunoglobulin A nephropathy: results of a multicenter cohort study |
Q43703528 | Role of proteinuria reduction in the progression of IgA nephropathy |
Q33886910 | Steroids in the treatment of IgA nephropathy to the improvement of renal survival: a systematic review and meta-analysis |
Q27005109 | The Treatment of IgA Nephropathy |
Q37090470 | The improvement of renal survival with steroid pulse therapy in IgA nephropathy |
Q37115267 | The predictive value of attenuated proteinuria at 1 year after steroid therapy for renal survival in patients with IgA nephropathy |
Q35852475 | Therapeutic approach of patients with IgA nephropathy |
Q38689787 | Treatment of IgA nephropathy with renal insufficiency |
Q38860793 | Why, when and how should immunosuppressive therapy considered in patients with immunoglobulin A nephropathy? |
Search more.